The emerging landscape of metabolic support in the UK is seeing significant interest in the synergy of high-dose NAD+ supplementation – often at 1 gram – and the novel GLP-1 receptor agonist Retatrutide (or https://majasfli898152.tinyblogging.com/nad-1000mg-retatrutide-a-uk-news-88258748